NCOA1 and urothelial carcinoma: Boorjian et al., 2009 looked for the participation of the coactivators NCOA1, NCOA2, NCOA3, CREBBP and EP300 with the AR activation urothelial carcinoma cells, finding their expression in bladder cancer and the differential regulation of NCOA1 [23].